These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39312103)

  • 1. Comment on "gemcitabine, PI3kinase-Akt pathway inhibition and radiation in human glioma cell lines" by M.S. Elnaggar et al.
    Balaji MB; Brahma N; Vimal S
    Med Oncol; 2024 Sep; 41(10):248. PubMed ID: 39312103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of BDNF/TrkB/PI3K/Akt signal mediated by AG1601 promotes apoptosis in malignant glioma.
    Yin H; Jiang Y; Zhang Y; Ge H; Yang Z
    J Cell Biochem; 2019 Nov; 120(11):18771-18781. PubMed ID: 31219215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma.
    Tang D; Gao W; Yang J; Liu J; Zhao J; Ge J; Chen Q; Liu B
    Mol Med Rep; 2020 Nov; 22(5):3804-3812. PubMed ID: 33000209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.
    Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R
    Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN reconstitution alters glioma responses to c-Met pathway inhibition.
    Goodwin CR; Lal B; Ho S; Woodard CL; Zhou X; Taeger A; Xia S; Laterra J
    Anticancer Drugs; 2011 Oct; 22(9):905-12. PubMed ID: 21654317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.
    von Achenbach C; Weller M; Kaulich K; Gramatzki D; Zacher A; Fabbro D; Reifenberger G; Szabó E
    J Neurochem; 2020 May; 153(4):510-524. PubMed ID: 31618458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway.
    Ma Y; Zhou G; Li M; Hu D; Zhang L; Liu P; Lin K
    Neurochem Int; 2018 Sep; 118():233-241. PubMed ID: 29572052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.
    Liu C; Wu H; Li Y; Shen L; Yu R; Yin H; Sun T; Sun C; Zhou Y; Du Z
    J Neurooncol; 2017 Nov; 135(2):263-272. PubMed ID: 28887597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low doses of PEG-coated gold nanoparticles sensitize solid tumors to cold plasma by blocking the PI3K/AKT-driven signaling axis to suppress cellular transformation by inhibiting growth and EMT.
    Kaushik NK; Kaushik N; Yoo KC; Uddin N; Kim JS; Lee SJ; Choi EH
    Biomaterials; 2016 May; 87():118-130. PubMed ID: 26921841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
    Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma.
    Guillard S; Clarke PA; Te Poele R; Mohri Z; Bjerke L; Valenti M; Raynaud F; Eccles SA; Workman P
    Cell Cycle; 2009 Feb; 8(3):443-53. PubMed ID: 19177002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gold-conjugated resveratrol nanoparticles on glioma cells and its underlying mechanism.
    Liu X; Guo Z; Li J; Wu D; Liu Z; Guan C; Guan Y; Lu X
    Biomed Mater Eng; 2024; 35(3):279-292. PubMed ID: 38461500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue.
    Fehlauer F; Muench M; Smid EJ; Slotman B; Richter E; Van der Valk P; Sminia P
    Oncol Rep; 2006 Jan; 15(1):97-105. PubMed ID: 16328040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amrubicin encapsulated PLGA NPs inhibits the PI3K/AKT signaling pathway by activating PTEN and inducing apoptosis in TMZ-resistant Glioma.
    Younis M; Shaikh S; Shahzad KA; Tan F; Wang Z; Lashari MH
    Biomed Mater; 2024 Jan; 19(2):. PubMed ID: 38181444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3-kinase/AKT pathway regulates the endoplasmic reticulum to golgi traffic of ceramide in glioma cells: a link between lipid signaling pathways involved in the control of cell survival.
    Giussani P; Brioschi L; Bassi R; Riboni L; Viani P
    J Biol Chem; 2009 Feb; 284(8):5088-96. PubMed ID: 19103588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandrin B suppresses glioma cell metastasis mediated by inhibition of mTOR/MMP-9 signal pathway.
    Jiang Y; Zhang Q; Bao J; Du C; Wang J; Tong Q; Liu C
    Biomed Pharmacother; 2015 Aug; 74():77-82. PubMed ID: 26349966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
    Jiang L; Wang C; Lei F; Zhang L; Zhang X; Liu A; Wu G; Zhu J; Song L
    Oncotarget; 2015 Apr; 6(10):8286-99. PubMed ID: 25823655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.